{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:01Z","timestamp":1761102241919,"version":"3.41.0"},"reference-count":15,"publisher":"Centers for Disease Control MMWR Office","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6546a3","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T16:32:34Z","timestamp":1479918754000},"page":"1291-1294","source":"Crossref","is-referenced-by-count":12,"title":["CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control"],"prefix":"10.15585","volume":"65","author":[{"given":"Juan L.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryll C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta M.","family":"Massetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Avner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Iskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muin J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R2","unstructured":"Petrucelli N, Daly MB, Feldman GL.BRCA1andBRCA2hereditary breast and ovarian cancer. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 2013. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247\/"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R3","unstructured":"Nelson HD, Fu R, Goddard K, Risk assessment, genetic counseling, and genetic testing forBRCA-related cancer: systematic review to update the U.S. Preventive Services Task Force recommendation evidence synthesis no. 101. Agency for Healthcare Research and Quality publication no. 12\u201305164-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2013."},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance.","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-159-10-201311190-00718","article-title":"Medications for risk reduction of primary breast cancer in women: US Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R7","unstructured":"Kohlmann W, Gruber SB. Lynch syndrome. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews [Internet]. Seattle WA: University of Washington, Seattle; 2014. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1211\/"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ncpgasthep0663","article-title":"Genetic testing for colon cancer.","volume":"3","author":"Kaz","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":"EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group","year":"2009","journal-title":"Genet Med"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/healthcare3040948","article-title":"The activities and impact of state programs to address hereditary breast and ovarian cancer, 2011\u20132014.","volume":"3","author":"Trivers","year":"2015","journal-title":"Healthcare (Basel)"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/clpt.2013.226","article-title":"Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.","volume":"95","author":"Dotson","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amepre.2010.12.009","article-title":"Current priorities for public health practice in addressing the role of human genomics in improving population health.","volume":"40","author":"Khoury","year":"2011","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/jama.2016.12260","article-title":"Will precision medicine improve population health?","volume":"316","author":"Khoury","year":"2016","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm6546a3-201611231051-R15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1200\/JCO.2015.66.0019","article-title":"Health care segregation, physician recommendation, and racial disparities in BRCA1\/2 testing among women with breast cancer.","volume":"34","author":"McCarthy","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:44:18Z","timestamp":1749761058000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6546a3.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":15,"journal-issue":{"issue":"46","published-online":{"date-parts":[[2016,11,25]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6546a3","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"type":"print","value":"0149-2195"},{"type":"electronic","value":"1545-861X"}],"subject":[],"published-other":{"date-parts":[[2016,11,25]]},"published":{"date-parts":[[2016,11,25]]}}}